Development and evaluation of an ensemble resource linking medications to their indications

Journal of the American Medical Informatics Association

Volumn 20, Issue 5, 2013, Pages 954-961

  Wei, Wei Qi ^a   Cronin, Robert M ^b   Xu, Hua ^c   Lasko, Thomas A ^a   Bastarache, Lisa ^a   Denny, Joshua C ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CIPROFLOXACIN; DEXMETHYLPHENIDATE; DOBUTAMINE; EPHEDRINE; GUAIFENESIN; ISOSORBIDE; SILDENAFIL;

ACCURACY; ADVERSE DRUG REACTION; ARTICLE; ASTHMA; CONSUMER HEALTH INFORMATION; CYSTIC FIBROSIS; DRUG INDICATION; DRUG RECALL; ELECTRONIC MEDICAL RECORD; FATIGUE; FOOD AND DRUG ADMINISTRATION; FULL TEXT DATABASE; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ICD-9; KNOWLEDGE BASE; MALAISE; MEDICAL ERROR; MEDICATION INDICATION RESOURCE; MEDLINE; NATURAL LANGUAGE PROCESSING; REFERENCE DATABASE; RHEUMATOID ARTHRITIS; RXNORM; SIDE EFFECT RESOURCE 2; SYSTEMATIZED NOMENCLATURE OF MEDICINE; TREATMENT OUTCOME; UNIFIED MEDICAL LANGUAGE SYSTEM; VISUAL DISORDER; WIKIPEDIA;

ELECTRONIC MEDICAL RECORDS; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICATION INDICATIONS; ONTOLOGY; TERMINOLOGY; UNIFIED MEDICAL LANGUAGE SYSTEM;

DICTIONARIES AS TOPIC; DRUG THERAPY; ELECTRONIC HEALTH RECORDS; INTERNET; MEDLINEPLUS; NATURAL LANGUAGE PROCESSING; PHARMACEUTICAL PREPARATIONS; RXNORM;

EID: 84882766694     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2012-001431     Document Type: Article

References (47)

1. Cebul RD, Love TE, Jain AK, et al. Electronic health records and quality of diabetes care. N Engl J Med 2011;365:825-33.
2. Ghitza UE, Sparenborg S, Tai B. Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems. Subst Abuse Rehabil 2011;2011:125-31.
3. Roth CP, Lim YW, Pevnick JM, et al. The challenge of measuring quality of care from the electronic health record. Am J Med Qual 2009;24:385-94.
4. Roth MT, Weinberger M, Campbell WH. Measuring the quality of medication use in older adults. J Am Geriatr Soc 2009;57:1096-102.
5. Tracy RP. 'Deep phenotyping': characterizing populations in the era of genomics and systems biology. Curr Opin Lipidol 2008;19:151-7.
6. Wilke RA, Xu H, Denny JC, et al. The emerging role of electronic medical records in pharmacogenomics. Clin Pharmacol Ther 2011;89:379-86.
7. DailyMed 2012; dailymed.nlm.nih.gov.
8. Epstein RS, Huang SM. The many sides of off-label prescribing. Clin Pharmacol Ther 2012;91:755-8.
9. Bates GW, Legro RS. Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol 2012, pii: S0303-7207(12)00481-9. doi: 10.1016/j. mce.2012.10.029. [Epub ahead of print 20 Dec 2012].
10. Tursi A. Acute diverticulitis of the colon-current medical therapeutic management. Expert Opin Pharmacother 2004;5:55-9.
11. Psaty BM, Ray W. FDA guidance on off-label promotion and the state of the literature from sponsors. JAMA 2008;299:1949-51.
12. Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008;371:117-25.
13. Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA 2011;305:2556-64.
14. Duke JD, Han X, Wang Z, et al. Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol 2012;8:e1002614.
15. Zhu F, Shi Z, Qin C, et al. Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res 2012;40:D1128-136.
16. Kuhn M, Campillos M, Letunic I, et al. A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol 2010;6:343.
17. Nelson SJ, Zeng K, Kilbourne J, et al. Normalized names for clinical drugs: RxNorm at 6 years. JAMIA 2011;18:441-348.
18. Bodenreider O, Peters LB. A graph-based approach to auditing RxNorm. J Biomed Inform 2009;42:558-70.
19. Warnekar PP, Bouhaddou O, Parrish F, et al. Use of RxNorm to exchange codified drug allergy information between Department of Veterans Affairs (VA) and Department of Defense (DoD). AMIA Annu Symp Proc 2007:781-5.
20. Denny JC, Peterson JF. Identi QT prolongation from ECG impressions using natural language processing and negation detection. Stud Health Technol Inform 2007;129 (Pt 2):1283-8.
21. Aronson AR, Lang FM. An overview of MetaMap: historical perspective and recent advances. JAMIA 2010;17:229-36.
22. Denny JC, Bastarache L, Sastre EA, et al. Tracking medical students' clinical experiences using natural language processing. J Biomed Inform 2009;42:781-9.
23. Denny JC, Peterson JF, Choma NN, et al. Extracting timing and status descriptors for colonoscopy testing from electronic medical records. JAMIA 2010;17:383-8.
24. Denny JC, Smithers JD, Miller RA, et al. "Understanding" medical school curriculum content using KnowledgeMap. JAMIA 2003;10:351-62.
25. Denny JC, Spickard A III, Miller RA, et al. Identifying UMLS concepts from ECG Impressions using KnowledgeMap. AMIA Ann Proc 2005:196-200.
26. SNOMED CT ICD9 CrossMap 2012; http://www.nlm.nih.gov/research/umls/licensedcontent/snomedctarchive.html (accessed 1 Jan 2013).
27. Martin MF, Surrall KE, McKenna F, et al. Captopril: a new treatment for rheumatoid arthritis?. Lancet 1984;1:1325-8.
28. Shea S, Hripcsak G. Accelerating the use of electronic health records in physician practices. N Engl J Med 2010;362:192-5.
29. CMS. EHR Incentive Programs 2012; https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/index.html (accessed 1 Jan 2013).
30. Carroll RJ, Thompson WK, Eyler AE, et al. Portability of an algorithm to identify rheumatoid arthritis in electronic health records. JAMIA 2012;19:e162-9.
31. Kho AN, Hayes MG, Rasmussen-Torvik L, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. JAMIA 2012;19:212-18.
32. Ritchie MD, Denny JC, Crawford DC, et al. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet 2010;86:560-72.
33. Wei W-Q, Leibson CL, Ransom JE, et al. Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus. JAMIA 2012;19:219-24.
34. Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. JAMIA.
35. Robinson PN. Deep phenotyping for precision medicine. Hum Mutat 2012;33:777-80.
36. Wei WQ, Leibson CL, Ransom JE, et al. The absence of longitudinal data limits the accuracy of high-throughput clinical phenotyping for identifying type 2 diabetes mellitus subjects. Int J Med Inform 2013;82:239-47.
37. Denny JC, Ritchie MD, Crawford DC, et al. Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science. Circulation 2010;122:2016-21.
38. Denny JC, Crawford DC, Ritchie MD, et al. Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome-and phenome-wide studies. Am J Hum Genet 2011;89:529-42.
39. McCarty CA, Chisholm RL, Chute CG, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011;4:13. doi: 10.1186/1755-8794-4-13. http://www.ncbi.nlm.nih.gov/pubmed/21269473
40. Liu M, Wu Y, Chen Y, et al. Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. JAMIA 2012;19:e28-35.
41. Burton MM, Simonaitis L, Schadow G. Medication and indication linkage: a practical therapy for the problem list?. AMIA Ann Symp Proc 2008:86-90.
42. Denny JC, Ritchie MD, Basford MA, et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 2010;26:1205-10.
43. Giles J. Internet encyclopaedias go head to head. Nature 2005;438:900-1.
44. epocrates. 2013; http://www.epocrates.com/(accessed 1 Jan 2013).
45. lexicomp 2013; http://www.utdol.com (accessed 1 Jan 2013).
46. Glueck CJ, Fontaine RN, Wang P, et al. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism 2001;50: 856-61.
47. Seifarth C, Schehler B, Schneider HJ. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Exp Clin Endocrinol Diabetes 2013;121:27-31.